Hikal has fared well in 2005-06 with a growth in both Turnover and Net profit. Hikal posted a 24% growth in turnover and registered a 21% increase in profits.

The pharmaceutical division grew at 68% to Rs. 83.4 crores and the crop protection division grew at 7% to Rs. 147 crores. We achieved exports of Rs. 178 crores, a growth of 16%.

Hikal has made a strategic investment in Jiangsu Chemstar Industries Co. Ltd., (a subsidiary company of Sinochem Corporation, China “A FORTUNE 500” company). Hikal acquired a 10% stake (with an option to invest up to 20%) in this year.

 
Financial Highlights :
 
   
(Rs in Million)
  2005-2006 2004-2005
Total Revenue 4,590.68 3,397.09
EBITDA 588.52 566.06
PBT 257.72 314.91
PAT 335.21 357.22
 
For More Details Click here >>
 


       
     

  Disclaimer | Sitemap | Best settings  
Investor Relation Investor Relation